
Is VRTX (Vertex Pharmaceuticals Incorporated) Halal or Haram?
Vertex Pharmaceuticals comfortably passes all AAOIFI Shariah screens, making it a Halal investment option. The company maintains an exceptionally low debt-to-market cap ratio of 3.5%, well below the 33% limit, and its cash and securities sit safely at 6.0%. While interest income accounts for 4.07% of revenue, it remains just under the 5% threshold, requiring Muslim investors to purify this small portion of their earnings.
Price Chart (5D)
VRTX — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 425.02 | 427.38 | 421.54 | 423.92 | 797K | -0.26% |
| 2026-04-30 | 423.66 | 430.95 | 423.66 | 427.38 | 1.1M | +0.88% |
| 2026-04-29 | 424.44 | 426.72 | 419.71 | 423.24 | 1.1M | -0.28% |
| 2026-04-28 | 431.25 | 431.77 | 426.68 | 430.14 | 809K | -0.26% |
| 2026-04-27 | 427.01 | 434.07 | 425.87 | 426.01 | 967K | -0.23% |
| 2026-04-24 | 431.89 | 433.68 | 427.38 | 430.29 | 1.1M | -0.37% |
| 2026-04-23 | 440.71 | 442.04 | 433.81 | 435.10 | 778K | -1.27% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for VRTX
Business Activity
Permissible
Vertex Pharmaceuticals passes the business activity screen because developing and commercializing life-saving biotechnology therapies, specifically for cystic fibrosis like TRIKAFTA and KALYDECO, is a highly permissible and beneficial activity.
Debt / Market Cap
3.55%
Interest Income
4.07%
Cash & Securities
6.04%
About Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily known for its groundbreaking therapies treating cystic fibrosis. The company develops and markets critical medications like TRIKAFTA, SYMDEKO, and KALYDECO, which target specific genetic mutations to improve patient outcomes. Its active pipeline also includes promising treatments for AAT deficiency and APOL1-mediated kidney diseases.
For Muslim investors, VRTX currently stands as a Halal investment opportunity, having successfully passed all four AAOIFI screening criteria. The company's core business of developing life-saving medical treatments aligns perfectly with Islamic values of preserving life and health. Practically, this means the stock can be confidently added to a Shariah-compliant portfolio without concerns over impermissible core operations.
From an Islamic finance perspective, Vertex boasts an incredibly strong balance sheet with a minimal debt-to-market cap ratio of just 3.5%. Its cash and interest-bearing securities also remain well within permissible limits at 6.0% of its market capitalization. However, investors should note that its interest income to revenue ratio is currently at 4.07%, which is compliant but nearing the 5% upper limit.
Because the interest income ratio is relatively close to the 5% threshold, Muslim shareholders must remain vigilant and monitor future quarterly earnings reports. Additionally, investors will need to calculate and purify the 4.07% of any dividends received to ensure their returns remain strictly Halal.
VRTX Key Financial Statistics
Revenue
$12.07B
Net Income
$3.95B
EPS (Diluted)
$15.32
Stock Price
430.14
Beta
0.37
52-Week Range
362.5-510.77
Total Debt
$3.88B
Total Equity
$18.67B
Current Ratio
2.90
VRTX Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+9.6%
Prior year: $11.02B
Net Cash
$1.21B
Cash: $5.09B — Debt: $3.88B
R&D Spending
$3.75B
% of Revenue
31.1%
Frequently Asked Questions About VRTX
Is VRTX (Vertex Pharmaceuticals Incorporated) stock halal to invest in?▾
What does Vertex Pharmaceuticals Incorporated do?▾
What screening criteria were used for VRTX?▾
Does VRTX require income purification?▾
When was VRTX last screened?▾
Disclaimer
This shariah compliance assessment for VRTX (Vertex Pharmaceuticals Incorporated) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.